Monopar Therapeutics·4

Jan 3, 3:58 PM ET

RIOUX PATRICE 4

4 · Monopar Therapeutics · Filed Jan 3, 2023

Insider Transaction Report

Form 4
Period: 2022-12-31
Transactions
  • Award

    Stock Options

    2023-01-01+10,00010,000 total
    Exercise: $2.37Exp: 2031-12-31Common Stock (10,000 underlying)
Footnotes (1)
  • [F1]Stock Options vesting commenced on January 1, 2023 as follows: 833 on January 31, 2023 and each subsequent month-end thereafter.

Documents

1 file
  • 4
    rdgdoc.xmlPrimary

    FORM 4